Home › NDC Lookup › Ingredients › Thyroid Tablets › 17224-0503-28
⚪image loading
(from DailyMed)

NP Thyroid Thyroid tablets 9 ug; 38 ug Tablet, 28-count — NDC 17224-503-28 (Billing 17224-0503-28)

by Calvin Scott & Co Inc. · 28 TABLET in 1 BOTTLE

This is a package of 28 tablets of NP Thyroid Thyroid tablets 9 ug; 38 ug Tablet from Calvin Scott & Co Inc., marketed since Aug 2025 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 17224-0503-28
🏷️ FDA NDC (as labeled) 17224-503-28 billing pads the product segment with a zero
This package
Contains28-count Pack sizes3 compare ↓
Main listing for product 17224-503 · Also comes in: 30 tablets 17224-503-30 60 tablets 17224-503-60
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 17224-503-28
Product NDC 17224-503
11-digit billing NDC 17224050328
RxCUI 313391, 1724481
UNII 06LU7C9H1V, Q51BO43MG4
SPL Set ID 3bff08d3-9878-b516-e063-6394a90a65e3
Established class (EPC) l-Triiodothyronine; l-Thyroxine
Chemical class Triiodothyronine; Thyroxine
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-08-01
Route ORAL
Dosage form TABLET
Substance LIOTHYRONINE; LEVOTHYROXINE
Quick answers
  • RxCUI (RxNorm): 313391
Why two NDCs? The FDA registers this code as 17224-503-28 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 17224-0503-28. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • Great question. Desiccated thyroid — the active ingredient in products like Amerithroid and Thyroid Tablets — is made from dried pig (porcine) thyroid glands. It naturally contains...
  • What exactly is desiccated thyroid, and is it different from the synthetic thyroid hormone my friend takes?
  • It does matter a bit. Fasting actually increases the absorption of thyroid hormones, so many people take their tablet first thing in the morning, about 30–60 minutes before eating....
  • Can I take my thyroid tablet with breakfast, or does it matter?
📖 Read our full Thyroid guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 30 tablets 60 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
17224-0503-28 You're viewing this Main listing 28 TABLET in 1 BOTTLE 2025-08-01 — Active
17224-0503-30 17224-503-30 30 TABLET in 1 BOTTLE 2025-08-01 — Active
17224-0503-60 17224-503-60 60 TABLET in 1 BOTTLE 2025-08-01 — Discontinued by firm

You're viewing the smallest of 3 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 28-count package — 28 tablet in 1 bottle.
How does this package differ from NDC 17224-0503-30?
Both are NP Thyroid Thyroid tablets 9 ug; 38 ug Tablet — the drug itself is identical. This page's package is the 28-count one, while NDC 17224-0503-30 is the 30 tablets package.
What NDC number is used to bill for this package of NP Thyroid Thyroid tablets 9 ug; 38 ug Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
NP Thyroid 60 38 ug/1; 9 ug 42192-0330-01 Acella 100 tablets $0.671 — Availability likely —
Thyroid 60 mg 62559-0742-01 ANI 100 tablets $0.671 — Availability likely —
Thyroid 60 mg 69680-0167-00 Vitruvias 100 tablets $0.671 — Availability likely —
EvexiTHROID 38 ug/1; 9 ug 73352-0696-10 Trifluent 100 tablets $0.671 — Availability likely —
Niva Thyroid 60 mg 75834-0312-01 Nivagen 100 tablets $0.671 — Availability likely —
Amerithroid 60 mg 82685-0343-01 Oliva 100 tablets $0.671 — Availability likely —
Armour Thyroid 60 mg 00456-0459-01 Allergan, 100 tablets $1.127 — Availability likely —
NP Thyroid 9 ug/1; 38 ugthis 17224-0503-28 Calvin 28 tablets — — FDA listed —
Armour Thyroid 60 mg 50090-0190-00 A-S 100 tablets — — FDA listed —
NP Thyroid 60 38 ug/1; 9 ug 50090-5216-00 A-S 90 tablets — — FDA listed —
NP Thyroid 60 38 ug/1; 9 ug 51655-0132-52 Northwind 30 tablets — — FDA listed —
RenThyroid 38 ug/1; 9 ug 64950-0172-01 Genus 100 tablets — — FDA listed —
NP Thyroid 60 38 ug/1; 9 ug 68071-3691-03 NuCare 30 tablets — — FDA listed —
NP Thyroid 60 38 ug/1; 9 ug 71335-0414-01 Bryant 60 tablets — — FDA listed —
Np Thyroid 60 9 ug/1; 38 ug 72189-0202-90 DIRECT 90 tablets — — FDA listed —
NP Thyroid 60 38 ug/1; 9 ug 76420-0568-01 Asclemed 100 tablets — — FDA listed —
Thyroid 60 mg 79739-7372-01 LGM 100 tablets — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Aug 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCalvin Scott & Co Inc.
Labeler code17224
First marketedAug 2025
Product typeHuman Otc Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 8 words ▾

Used as a thyroid hormone replacement for hypothyroidism.

⏱️ Dosage and Administration 11 words ▾

Take 1 tablet daily on an empty stomach or as directed.

⚠️ Warnings 11 words ▾

Do not exceed recommended dose. Keep out of reach of children.

🧪 Active Ingredient 3 words ▾

Thyroid 60 mg

🧪 Inactive Ingredients 9 words ▾

Calcium stearate, dextrose, maltodextrin, mineral oil, modified wheat starch

🎯 Purpose 3 words ▾

Thyroid hormone replacement

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. In case of accidental overdose, contact a doctor or Poison Control Center immediately.

📄 Package Label / Principal Display Panel 33 words ▾

NDC 17224-503-60 Package label for NP Thyroid 60 mg tablets (60 tablets per bottle). Contains product name, dosage strength, NDC 17224-503-60, manufacturer/repacker name, and usage instructions as printed on the label. NDC 17224-503-60

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for NP Thyroid — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name NP Thyroid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$2.94M
Claims incl. refills
55.6K
Beneficiaries
38.4K
Spend / beneficiary
$76.62
Spend / claim
$52.82
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Calvin Scott & Co Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 30 tablets (17224-0503-30), 60 tablets (17224-0503-60). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Calvin Scott & Co Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 17224-0502-30 · Calvin 17224-0504-30 · Calvin →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.